Elmiron Users Are Advised To Make Lifestyle Changes

Some recommendations are as simple as doing gentle exercises such as walking, yoga, or low-impact aerobics

Wednesday, October 28, 2020 - Interstitial Cystitis (IC) is also known as painful bladder syndrome. Elmiron is the only drug available on the market to treat the condition. Individuals with IC tend to avoid sex because it is painful and also have to urinate frequently. It can take several months of taking Elmiron regularly for IC pain to begin to subside. Janssen Pharmaceuticals recommends that patients include changes to their diet and lifestyle to help treat the condition. The first step is avoiding certain foods like those that contain "caffeine or alcohol, aged, canned, cured, processed, and smoked meats and fish, spicy foods, acidic foods and drinks, anything with artificial sweeteners such as aspartame, anything with preservatives, such as citric acid and monosodium glutamate (MSG)." IC patients should make the following lifestyle changes to mitigate their IC discomfort. Patients should "apply warm or cold compresses on the lower abdomen, use stress-reduction techniques like controlled breathing exercises, try gentle exercises such as walking, yoga, or low-impact aerobics, and to try bladder retraining (lengthening the time between bathroom visits)," according to Ortho Elmiron.com. Elmiron eyesight damage lawsuits represented by top national attorneys offering a free consultation and no obligation to file a claim.

Long-term users of Elmiron, a drug taken to alleviate painful bladder syndrome, have developed permanent eyesight damage called pigmentary maculopathy. Drugwatch.com describes Pigmentary maculopathy as, "a unique type of maculopathy linked to interstitial cystitis (IC) drug Elmiron (pentosan polysulfate sodium). Some people who used the drug long-term for treating IC and bladder pain developed pigmented deposits that resemble little specks in the macula, according to a 2018 study," Many have filed suit against the drug's maker Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson accusing the companies of failing to warn them of the dangers of the drug until just recently. OrthoElmiron.com, the drug's official website, now warns Elmiron users of the drug's toxic potential. "Visual symptoms that have been reported include, difficulty reading, slow adjustment to low or reduced light environments, and blurred vision." Since macular degeneration is normally a condition that affects older individuals, taking Elmiron is thought to cause early onset of the condition. The company recommends that people taking Elmiron to be examined annually by an ophthalmologist to identify signs of macular degeneration at its earliest stages. The company concedes that macular degeneration could be permanent and increase even though a patient stops taking the medicine. In addition to those with macular degeneration who have filed lawsuits studies performed at Kaiser Permanente indicate that as many as one in four long-term Elmiron patients could be affected by eyesight damage.

Millions of people may be taking their eyesight problems for granted and chalking them up to simply getting older, when in fact they may be due to using Elmiron for more than one year. If you have been taking Elmiron and are having difficulty reading or problems seeing in low-light settings you should see an ophthalmologist immediately. If you are diagnosed with macular degeneration you should consult an Emiron Eyesight Damage Attorney as you may be able to file a claim for significant lump sum monetary damages.

More Recent Elmiron Eye Lawsuit News:

Lawyers for Elmiron Eye Lawsuits

Attorneys handling Elmiron Eye lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Elmiron Eye lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Elmiron Eye lawsuit. The product liability litigators handling Roundup claims at OnderLaw have a strong track record of success in representing families harmed by dangerous drugs and consumer products.